Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro.
第一作者:
Richard A,Slivicki
第一单位:
Program in Neuroscience, Indiana University, Bloomington, IN, United States; Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States.
作者:
主题词
酰胺基水解酶类(Amidohydrolases);镇痛药(Analgesics);动物(Animals);抗肿瘤药(Antineoplastic Agents);苯甲酰胺类(Benzamides);苯并恶嗪类(Benzoxazines);脑(Brain);大麻酚类(Cannabinoids);氨甲酸酯类(Carbamates);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);药物协同作用(Drug Synergism);药物耐受性(Drug Tolerance);HEK293细胞(HEK293 Cells);人类(Humans);痛觉过敏(Hyperalgesia);男(雄)性(Male);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);吗啉类(Morpholines);萘类(Naphthalenes);神经痛(Neuralgia);紫杉酚(Paclitaxel);物质相关性障碍(Substance-Related Disorders)
DOI
10.1016/j.phrs.2019.02.002
PMID
30739035
发布时间
2021-02-23
- 浏览8

Pharmacological research
267-282页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文